Viewing Study NCT05824494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-01-04 @ 4:59 PM
Study NCT ID: NCT05824494
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-06
First Post: 2023-04-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Cervical Neoplasms View
None Cancer of Cervix View
None Cervical Cancer View
None Cervical Neoplasms View
None Uterine Cervical Cancer View
None Cancer of the Uterine Cervix View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PD-1 View
None immune checkpoint inhibitor View